The first vaccine that prevents some cervical cancer-causing forms of the human papilloma virus (HPV) in women, may also stop men from spreading the virus and contracting cancer.Jennifer Mallory, a spokeswoman for Edelman, a New York City-based PR firm that represents Merck and Co., said the company is continuing to conduct clinical trials with the vaccine, called Gardasil, on males. It plans to seek Federal Drug Administration approval for use on boys and men once those trials are complete.>>> Discuss This Story
